News

2Q20 Earnings Release

São Paulo, August 20th, 2020- Alliar - Centro de Imagem Diagnósticos S.A. hereby announces its 2Q20 results.

Highlights:

  • Alliar signs exclusive commercial representation agreement with Medic Vision - a Israeli HealthTech company that uses Machine Learning algorithms for significant productivity gains in MRI exams
  • Clinical Analysis reported record share, accounting for 24% of the quarter revenue, compared to the historical average of 13%;
  • iDr doubles the volume of signed contracts and accounts for 1,5% of Alliar’s total revenue;
  • The private segment reported record share, accounting for more than 20% of revenue, an important milestone for the diversification of paying sources;
  • Gross Revenue of R$150.8 million, negative adjusted EBITDA of R$26.5 million, mainly impacted by
    the results of April and May, which led to a negative Net result (Shareholders) of R$84.6 million;
  • Operational Cash Generation of R$34.1 million, showing Alliar’s cash generation capacity, despite
    the decrease in revenue;
  • Robust cash, of R$325.3 million at the end of the year.

Click here to access the Earnings Release.

Conference Call in Portuguese

August 21st, 2020
12:30 p.m. (Local time)
11:30 a.m. (NY time)
Phone: +55 (11) 2188-0155
Code: Alliar
Webcast: click here

IR Contact

Sami Foguel
CEO / IRO
Email:
ri@alliar.com